The New BIOTRONIK Home Monitoring^®

The first wireless remote monitoring technology with an intelligent traffic light system for focused, efficient patient care.

Eight years ago, BIOTRONIK was the first to develop wireless remote monitoring. It's that experience, along with extensive customer-oriented research that has earned the company its status as the leading pioneer in remote monitoring for patients with implantable cardiac devices.

Continuing its long tradition of leadership in the telecardiology industry, BIOTRONIK once again breaks new ground with the introduction of the most advanced wireless remote monitoring technology on the market today - The new BIOTRONIK Home Monitoring with an intelligent traffic light system.

Using an intuitive, color-coded traffic light system, BIOTRONIK Home Monitoring quickly and easily identifies patients with the most clinically relevant events in just one click to help streamline clinic workflows while providing simplicity of care any time, anywhere.

This advanced technology also improves patient care by enabling early detection of changes in patient or device status, allowing for fast and early intervention to prevent the patient's condition from further deteriorating.

The US Food and Drug Administration (FDA) recently approved an expanded labelling for BIOTRONIK Home Monitoring to include a safe reduction in in-office device follow-ups and provide early detection of symptomatic and asymptomatic cardiac arrhythmias, enabling earlier intervention than is possible with conventional in-office follow-ups.

BIOTRONIK Home Monitoring. It's proven to ensure patient safety.¹  Proven to reduce workload. 

We welcome you to take an in-depth look inside and experience all the benefits BIOTRONIK Home Monitoring has to offer.

¹ N. Varma, A. Epstein, R. Schweikert, C. Love, J. Shah, A. Irimpen: Evaluation of efficacy and safety of remote monitoring for ICD follow-up: the TRUST trial. Circulation 2008; 118; 2309-2317, Abstract 4078

* BIOTRONIK Home Monitoring is the first and only remote monitoring system with FDA and CE approval to provide early detection of clinically relevant events and to safely replace conventional device interrogation during follow-ups.